Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI Floxuridine/Dexamethasone + Systemic Chemotherapy in Colorectal Cancer Liver Metastases
NCT00492999Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2007
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine, dexamethasone in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started May 2007; status: active, not recruiting.
02
Drugs
floxuridinedexamethasone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00492999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492999.